バイオマーカー探索アウトソーシングサービス市場規模、シェア、動向分析レポート：バイオマーカータイプ別、治療領域別、フェーズ別、最終用途別、地域別、セグメント別予測、2025年～2030年

バイオマーカー探索アウトソーシングサービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、バイオマーカー探索アウトソーシングサービスの世界市場規模は、2025～2030年にかけてCAGR 19.4%で成長し、2030年までに412億7,000万米ドルに達する見込みです。

臨床検査におけるバイオマーカー利用の増加や製薬企業によるアウトソーシングの加速に起因するバイオマーカー調査のアウトソーシング拡大は、この市場の主要な成長要因です。

さらに、リキッドバイオプシーの採用が増加していることも、市場の成長を促進すると予想されます。血液、尿、脳脊髄液などの体液中のバイオマーカーを分析するリキッドバイオプシーは、従来の組織生検に比べて侵襲性が低く、リアルタイムで情報が得られるなど、いくつかの利点があります。その結果、リキッドバイオプシーの採用は急速に拡大しており、この動向はバイオマーカー探索アウトソーシングサービスの需要に直接影響を及ぼしています。

オミクス技術の進歩は、今後数年間の市場成長を促進すると予想されます。ゲノム、プロテオミクス、メタボロミクス、その他のオミクス技術の進歩により、新規バイオマーカーの同定が可能になりました。多くのオミクスセグメントのデータを統合することは、バイオマーカー同定に有利な場合が多いです。マルチオミクス・データ統合を専門とするアウトソーシングサービスは、このセグメントにおける貴重な専門知識を記載しています。

医薬品開発と臨床検査の増加が市場成長の主要要因です。バイオマーカーは医薬品開発において重要な役割を果たしており、製薬会社が適切な創薬標的を特定し、臨床検査プロセスを合理化し、検査に参加する患者集団を選択するのに役立っています。2023年現在、世界の臨床検査の状況は、ClinicalTrials.govに45万2,604件の臨床検査が登録されており、6万4,838人が積極的に参加者を登録しています。これは、2021年初頭に記録された約36万5,000件の登録検査と比較して顕著な急増を反映しており、臨床研究セグメントにおける堅調かつ継続的な成長を裏付けています。

バイオマーカー探索アウトソーシングサービス市場のレポートハイライト

• バイオマーカーのタイプ別では、代替エンドポイントセグメントが2024年に54.88%の最大売上シェアを占めました。
• 治療領域別では、腫瘍学、神経学、循環器学、自己免疫疾患、その他。
• フェーズ別では、2024年にはバイオマーカー同定セグメントが市場で最大の収益シェアを占めました。
• 最終用途に基づき、市場は製薬企業、バイオテクノロジー企業、その他に区分されます。
• 北米のバイオマーカー探索アウトソーシングサービス産業は、2024年に43.96%の最大市場シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオマーカー探索アウトソーシングサービス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 技術
  • バイオマーカー研究におけるAIとビッグデータの統合
  • オミクス技術
  • バイオインフォマティクスとクラウドコンピューティングの役割
• 価格モデル分析
• バリューチェーン分析
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 バイオマーカー探索アウトソーシングサービス市場：バイオマーカータイプ別、推定・動向分析

• バイオマーカー探索アウトソーシングサービス市場、バイオマーカータイプ別：セグメントダッシュボード
• バイオマーカー探索アウトソーシングサービス市場、バイオマーカータイプ別：変動分析
• バイオマーカータイプ別、2018～2030年
• 予測バイオマーカー
• 予後バイオマーカー
• 安全バイオマーカー
• 代理エンドポイント

第5章 バイオマーカー探索アウトソーシングサービス市場：治療領域別、推定・動向分析

• バイオマーカー探索アウトソーシングサービス市場、治療領域別：セグメントダッシュボード
• バイオマーカー探索アウトソーシングサービス市場、治療領域別：変動分析
• 治療領域別、2018～2030年
• 腫瘍学
• 神経学
• 心臓病学
• 自己免疫疾患
• その他

第6章 バイオマーカー探索アウトソーシングサービス市場：フェーズ別、推定・動向分析

• バイオマーカー探索アウトソーシングサービス市場、フェーズ別：セグメントダッシュボード
• バイオマーカー探索アウトソーシングサービス市場、フェーズ別：変動分析
• フェーズ別、2018～2030年
• バイオマーカーの特定
• バイオマーカーの検証
• バイオマーカープロファイリング
• バイオマーカーパネル開発
• バイオマーカーの選択

第7章 バイオマーカー探索アウトソーシングサービス市場：最終用途別、推定・動向分析

• バイオマーカー探索アウトソーシングサービス市場、最終用途別：セグメントダッシュボード
• バイオマーカー探索アウトソーシングサービス市場、最終用途別：変動分析
• 最終用途別、2018～2030年
• 製薬会社
• バイオテクノロジー企業
• その他

第8章 バイオマーカー探索アウトソーシングサービス市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
  • マーケットリーダー
  • 新興参入企業
• 企業市場シェア/評価分析、2024年
• 企業プロファイル
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories
  • Eurofins Scientific
  • Celerion
  • ICON plc.
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec

List of Tables

• Table. 1 List of Secondary Sources
• Table. 2 List of Abbreviations
• Table. 3 Global Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 4 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 5 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 6 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 7 Global Biomarker Discovery Outsourcing Services Market, by Region, 2018 - 2030 (USD Million)
• Table. 8 North America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 9 North America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 10 North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 11 North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 12 North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 13 U.S. Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 14 U.S. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 15 U.S. Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 16 U.S. Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 17 Canada Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 18 Canada Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 19 Canada Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 20 Canada Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 21 Mexico Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 22 Mexico Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 23 Mexico Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 24 Mexico Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 25 Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 26 Europe Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 27 Europe Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 28 Europe Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 29 Europe Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 30 Germany Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 31 Germany Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 32 Germany Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 33 Germany Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 34 UK Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 35 UK Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 36 UK Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 37 UK Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 38 France Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 39 France Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 40 France Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 41 France Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 42 Italy Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 43 Italy Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 44 Italy Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 45 Italy Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 46 Spain Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 47 Spain Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 48 Spain Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 49 Spain Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 50 Denmark Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 51 Denmark Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 52 Denmark Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 53 Denmark Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 54 Sweden Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 55 Sweden Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 56 Sweden Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 57 Sweden Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 58 Norway Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 59 Norway Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 60 Norway Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 61 Norway Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 62 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 63 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 64 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 65 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 66 Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 67 China Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 68 China Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 69 China Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 70 China Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 71 Japan Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 72 Japan Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 73 Japan Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 74 Japan Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 75 India Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 76 India Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 77 India Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 78 India Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 79 South Korea Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 80 South Korea Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 81 South Korea Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 82 South Korea Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 83 Australia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 84 Australia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 85 Australia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 86 Australia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 87 Thailand Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 88 Thailand Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 89 Thailand Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 90 Thailand Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 91 Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 92 Latin America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 93 Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 94 Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 95 Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 96 Brazil Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 97 Brazil Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 98 Brazil Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 99 Brazil Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 100 Argentina Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 101 Argentina Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 102 Argentina Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 103 Argentina Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 104 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 105 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 106 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 107 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 108 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 109 South Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 110 South Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 111 South Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 112 South Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 113 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 114 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 115 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 116 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 117 UAE Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 118 UAE Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 119 UAE Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 120 UAE Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 121 Kuwait Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 122 Kuwait Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 123 Kuwait Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 124 Kuwait Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Biomarker Discovery Outsourcing Services, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Biomarker Discovery Outsourcing Services, for Predictive Biomarkers, 2018 - 2030 (USD Million)
• Fig. 13 Global Biomarker Discovery Outsourcing Services, for Prognostic Biomarkers, 2018 - 2030 (USD Million)
• Fig. 14 Global Biomarker Discovery Outsourcing Services, for Safety Biomarkers, 2018 - 2030 (USD Million)
• Fig. 15 Global Biomarker Discovery Outsourcing Services, for Surrogate Endpoints, 2018 - 2030 (USD Million)
• Fig. 16 Global Biomarker Discovery Outsourcing Services, for Oncology, 2018 - 2030 (USD Million)
• Fig. 17 Global Biomarker Discovery Outsourcing Services, for Neurology, 2018 - 2030 (USD Million)
• Fig. 18 Global Biomarker Discovery Outsourcing Services, for Cardiology, 2018 - 2030 (USD Million)
• Fig. 19 Global Biomarker Discovery Outsourcing Services, for Autoimmune Diseases, 2018 - 2030 (USD Million)
• Fig. 20 Global Biomarker Discovery Outsourcing Services, for Other Therapeutic Area, 2018 - 2030 (USD Million)
• Fig. 21 Global Biomarker Discovery Outsourcing Services, for Biomarker Identification, 2018 - 2030 (USD Million)
• Fig. 22 Global Biomarker Discovery Outsourcing Services, for Biomarker Validation, 2018 - 2030 (USD Million)
• Fig. 23 Global Biomarker Discovery Outsourcing Services, for Biomarker Profiling, 2018 - 2030 (USD Million)
• Fig. 24 Global Biomarker Discovery Outsourcing Services, for Biomarker Panel Development, 2018 - 2030 (USD Million)
• Fig. 25 Global Biomarker Discovery Outsourcing Services, for Biomarker Selection, 2018 - 2030 (USD Million)
• Fig. 26 Global Biomarker Discovery Outsourcing Services, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
• Fig. 27 Global Biomarker Discovery Outsourcing Services, for Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 28 Global Biomarker Discovery Outsourcing Services, for Other End Use, 2018 - 2030 (USD Million)
• Fig. 29 Regional Outlook, 2024 & 2030
• Fig. 30 North America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Canada Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Mexico Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Europe Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 UK Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Germany Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 France Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Italy Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Spain Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Denmark Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Sweden Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Norway Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Asia Pacific Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 China Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Japan Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 South Korea Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Thailand Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Argentina Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 MEA Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 South Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 UAE Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Biomarker Discovery Outsourcing Services Market Growth & Trends:

The global biomarker discovery outsourcing services market size is expected to reach USD 41.27 billion by 2030, growing at a CAGR of 19.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The expansion of outsourced biomarker research, attributed to the increased utilization of biomarkers in clinical trials and the accelerating level of outsourcing undertaken by pharmaceutical firms are key growth factors for this market.

Furthermore, increasing adoption of liquid biopsies is expected to drive the market growth. Liquid biopsies, which involve the analysis of biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid, offer several advantages over traditional tissue biopsies, such as being less invasive and providing real-time information. As a result, the adoption of liquid biopsies has been growing rapidly, and this trend directly impacts the demand for biomarker discovery outsourcing services.

Advancements in omics technologies are expected to drive market growth in the coming years. Progress in genomics, proteomics, metabolomics, and other omics technologies has enabled the identification of novel biomarkers.Integrating data from many omics disciplines can often be advantageous for biomarker identification. This all-encompassing approach enables a more thorough comprehension of complex disorders and can result in identifying reliable, multidimensional biomarkers.Outsourcing services specializing in multi-omics data integration offer valuable expertise in this area.

An increase in drug development and clinical trials is a major contributing factor to the market growth. Biomarkers play a crucial role in drug development, helping pharmaceutical companies identify suitable drug targets, streamline clinical trial processes, and select patient populations for trials.As of 2023, the global clinical trial landscape boasts 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This reflects a notable surge compared to the roughly 365,000 registered trials documented in early 2021, underscoring the robust and ongoing growth within the field of clinical research.

Biomarker Discovery Outsourcing Services Market Report Highlights:

• Based on biomarker type, the surrogate endpoints segment accounted for the largest revenue share of 54.88% in 2024.
• Based on therapeutic areas, the market includes oncology, neurology, cardiology, autoimmune diseases, and others.
• Based on the discovery phase, in 2024, the biomarker identification segment accounted for the largest revenue share in the market.
• Based on end use, the market is segmented into pharmaceutical companies, biotechnology companies, and others.
• The biomarker discovery outsourcing services industry in North America accounted for the largest market share of 43.96% in 2024.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Biomarkers in Drug Development
    • 3.2.1.2. Expanding R&D Investment in Biopharmaceuticals
    • 3.2.1.3. Rising Prevalence of Chronic and Infectious Diseases
    • 3.2.1.4. Increasing focus on personalized medicine and targeted therapies
    • 3.2.1.5. Advancements in Omics Technologies
    • 3.2.1.6. Increasing Role of CROs and CDMOs Owing to Cost and Time Efficiency
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited Reproducibility & Validation Challenges
    • 3.2.2.2. High Cost of Biomarker Discovery & Validation
    • 3.2.2.3. Data Privacy & Security Concerns
• 3.3. Technology Landscape
  • 3.3.1. Integration of AI and Big Data in Biomarker Research
  • 3.3.2. Omics Technologies
  • 3.3.3. Role of Bioinformatics & Cloud Computing
• 3.4. Pricing Model Analysis
• 3.5. Value Chain Analysis
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Biomarker Discovery Outsourcing Services Market: Biomarker Type Estimates & Trend Analysis

• 4.1. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Segment Dashboard
• 4.2. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Movement Analysis
• 4.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Biomarker Type, 2018 - 2030 (USD Million)
• 4.4. Predictive Biomarkers
  • 4.4.1. Predictive Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Prognostic Biomarkers
  • 4.5.1. Prognostic Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Safety Biomarkers
  • 4.6.1. Safety Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Surrogate Endpoints
  • 4.7.1. Surrogate Endpoints Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Segment Dashboard
• 5.2. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Movement Analysis
• 5.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
• 5.4. Oncology
  • 5.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Neurology
  • 5.5.1. Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Cardiology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Autoimmune Diseases
  • 5.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Other Therapeutic Area
  • 5.8.1. Other Therapeutic Area Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biomarker Discovery Outsourcing Services Market: Discovery Phase Estimates & Trend Analysis

• 6.1. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Segment Dashboard
• 6.2. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Movement Analysis
• 6.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Discovery Phase, 2018 - 2030 (USD Million)
• 6.4. Biomarker Identification
  • 6.4.1. Biomarker Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Biomarker Validation
  • 6.5.1. Biomarker Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Biomarker Profiling
  • 6.6.1. Biomarker Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Biomarker Panel Development
  • 6.7.1. Biomarker Panel Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Biomarker Selection
  • 6.8.1. Biomarker Selection Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biomarker Discovery Outsourcing Services Market: End Use Estimates & Trend Analysis

• 7.1. Biomarker Discovery Outsourcing Services Market, By End Use: Segment Dashboard
• 7.2. Biomarker Discovery Outsourcing Services Market, By End Use: Movement Analysis
• 7.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
• 7.4. Pharmaceutical Companies
  • 7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Biotechnology Companies
  • 7.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Biomarker Discovery Outsourcing Services Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Thailand
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Australia
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Share/Assessment Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Laboratory Corporation of America Holdings
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Charles River Laboratories
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Eurofins Scientific
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Celerion
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. ICON plc.
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Parexel International (MA) Corporation
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Proteome Sciences
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. GHO Capital
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Thermo Fisher Scientific Inc.
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Evotec
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives